arrow
E

Etienne Sochett

sinai health system toronto
H指数:43
被引数:5,193

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period

Burosumab与X连锁低磷血症患儿的常规治疗: 开放标签,3期延长期的结果

2024-01-043
OAAI
Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level

Burosumab与磷酸盐/活性维生素d在小儿X连锁低磷血症中的作用: 剂量水平的亚组分析

2023-04-219
OA
Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia
2021-01-2331
OAAI
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
LANCET
IF88.5
2019-06-01242
OAAI
Association between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetes
2019-03-2813
OAAI
Elevated high-density lipoprotein in adolescents with Type 1 diabetes is associated with endothelial dysfunction in the presence of systemic inflammation

青少年1型糖尿病患者高密度脂蛋白升高与全身炎症时内皮功能障碍相关

2019-03-1239
OAAI
Plasma Uric Acid (PUA), Renal Hemodynamic Function, and Arterial Stiffness at the Extremes of T1D Duration-Adolescents vs. Adults with T1D for=50 Years
2018-07-010
PRE